Bruker Co. (NASDAQ:BRKR) has been assigned an average rating of “Hold” from the twelve ratings firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating on the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $59.11.
Several research firms have recently commented on BRKR. Stifel Nicolaus raised their price objective on shares of Bruker from $48.00 to $65.00 and gave the company a “hold” rating in a research note on Wednesday, February 17th. Wells Fargo & Company lowered shares of Bruker from an “overweight” rating to an “equal weight” rating and raised their price objective for the company from $50.00 to $55.00 in a research note on Friday, February 5th. Citigroup raised their price objective on shares of Bruker from $57.00 to $65.00 in a research note on Wednesday, February 17th. Finally, SVB Leerink raised their price objective on shares of Bruker from $50.00 to $70.00 and gave the company an “outperform” rating in a research note on Wednesday, January 27th.
In related news, Director Cynthia M. Friend sold 1,800 shares of the firm’s stock in a transaction that occurred on Monday, March 22nd. The shares were sold at an average price of $60.43, for a total value of $108,774.00. Following the sale, the director now owns 10,486 shares of the company’s stock, valued at $633,668.98. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 26.80% of the stock is owned by company insiders.
BRKR stock traded down $0.41 during mid-day trading on Tuesday, hitting $68.24. 10,383 shares of the company were exchanged, compared to its average volume of 471,687. The company has a quick ratio of 1.65, a current ratio of 2.67 and a debt-to-equity ratio of 0.86. The firm has a market capitalization of $10.34 billion, a P/E ratio of 67.06, a PEG ratio of 7.11 and a beta of 1.29. The business has a fifty day simple moving average of $65.78 and a 200-day simple moving average of $57.15. Bruker has a 12-month low of $35.98 and a 12-month high of $70.62.
Bruker (NASDAQ:BRKR) last announced its earnings results on Monday, February 15th. The medical research company reported $0.58 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.56 by $0.02. The company had revenue of $627.50 million during the quarter, compared to analyst estimates of $624.80 million. Bruker had a net margin of 8.04% and a return on equity of 21.78%. Research analysts predict that Bruker will post 1.33 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Friday, March 19th. Investors of record on Friday, March 5th were issued a $0.04 dividend. The ex-dividend date of this dividend was Thursday, March 4th. This represents a $0.16 annualized dividend and a yield of 0.23%. Bruker’s dividend payout ratio (DPR) is 10.19%.
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies.
Recommended Story: What are municipal bonds?
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.